4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000082
Chief Financial Officer gave up 661 shares (to pay taxes)
- Chief Financial Officer acquired 2,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adams Kendra · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-16 | Exercise or conversion : show line 1 in the form | +2,250 | 84,289 | D | ||
| 2024-09-16 | Shares withheld for taxes : show line 2 in the form | −661 | $6.36 | $4,204 | 83,628 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-16 | Exercise or conversion : show line 3 in the form Performance Restricted Stock Units | −2,250 | 14,250 | D |
Loading xslF345X05/wk-form4_1726607540.xml…